Does CARMUSTINE Cause Neoplasm progression? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Neoplasm progression have been filed in association with CARMUSTINE (carmustine). This represents 1.1% of all adverse event reports for CARMUSTINE.
38
Reports of Neoplasm progression with CARMUSTINE
1.1%
of all CARMUSTINE reports
24
Deaths
27
Hospitalizations
How Dangerous Is Neoplasm progression From CARMUSTINE?
Of the 38 reports, 24 (63.2%) resulted in death, 27 (71.1%) required hospitalization, and 3 (7.9%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Myelodysplastic syndrome (295)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Second primary malignancy (141)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which CARMUSTINE Alternatives Have Lower Neoplasm progression Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB